KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) FCF Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -7.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -537.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -911.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 1,568.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 534.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 913.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 9,115.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -1,716.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,716.00
Dec 31, 2025 -1,312.00
Sep 30, 2025 1,835.00
Jun 30, 2025 1,225.00
Mar 31, 2025 -1,543.00
Dec 31, 2024 172.00
Sep 30, 2024 131.00
Jun 30, 2024 -744.00
Mar 31, 2024 -1,148.00
Dec 31, 2023 642.00
Sep 30, 2023 2,015.00
Jun 30, 2023 -2,856.00
Mar 31, 2023 -1,105.00
Dec 31, 2022 166.00
Sep 30, 2022 -872.00
Jun 30, 2022 -1,343.00
Mar 31, 2022 1,052.00
Dec 31, 2021 -2,348.00
Sep 30, 2021 2,444.00
Jun 30, 2021 929.00
Mar 31, 2021 1,495.00
Dec 31, 2020 1,192.00
Sep 30, 2020 -756.00
Jun 30, 2020 1,709.00
Mar 31, 2020 2,323.00
Dec 31, 2019 385.00
Sep 30, 2019 1,779.00
Jun 30, 2019 2,651.00
Mar 31, 2019 3,074.00
Dec 31, 2018 4,069.00
Sep 30, 2018 1,141.00
Jun 30, 2018 1,732.00
Mar 31, 2018 590.00
Dec 31, 2017 689.00
Sep 30, 2017 732.00
Jun 30, 2017 165.00
Mar 31, 2017 -153.00
Dec 31, 2016 -680.00
Sep 30, 2016 -126.00
Jun 30, 2016 -3,123.00
Mar 31, 2016 347.00
Dec 31, 2015 -180.00
Sep 30, 2015 -11,190.00
Jun 30, 2015 -2,524.00
Mar 31, 2015 710.00
Dec 31, 2014 -1,734.00
Sep 30, 2014 -990.00
Jun 30, 2014 557.00
Mar 31, 2014 499.00
Dec 31, 2013 -152.00
Sep 30, 2013 -412.00
Jun 30, 2013 1,458.00
Mar 31, 2013 -2,114.00
Dec 31, 2012 -704.00
Sep 30, 2012 9,180.00